| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Edmund Harrigan | Director | 2026-03-31 | 269 | $94.12 | $25.32kBuy |
| Paul J. Clancy | Director | 2026-03-31 | 265 | $94.12 | $24.94kBuy |
| Matteo Trotta | EVP GM Dermatology US | 2026-03-25 | 537 | $92.23 | $49.53kSell |
| Pablo J. Cagnoni | President RD | 2026-03-17 | 7,166 | $61.18 | $438.42kBuy |
| Pablo J. Cagnoni | President RD | 2026-03-17 | 11,501 | $64.25 | $738.94kBuy |
| Pablo J. Cagnoni | President RD | 2026-03-17 | 18,667 | $94.24 | $1.76MSell |
| Pablo J. Cagnoni | President RD | 2026-02-19 | 13,093 | $61.76 | $808.62kBuy |
| Pablo J. Cagnoni | President RD | 2026-02-19 | 18,668 | $100.91 | $1.88MSell |
| Pablo J. Cagnoni | President RD | 2026-02-19 | 5,575 | $61.18 | $341.08kBuy |
| Lee Heeson | EVP Head of Incyte Intl | 2026-02-02 | 111 | $102.67 | $11.40kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Bros Advisors LP | 15.45% | 30,743,991 | $2.95B | Institution |
| Vanguard Group Inc | 10.01% | 19,911,434 | $1.91B | Institution |
| Julian Baker | 9.98% | 19,851,744 | $1.90B | Insider |
| Blackrock Inc | 9.21% | 18,327,923 | $1.76B | Institution |
| Dodge Cox | 6.66% | 13,261,742 | $1.27B | Institution |
| Baker Brothers Life Sciences LP | 6.25% | 12,445,783 | $1.19B | Insider |
| Baker Brothers Life Sciences Capital GP LLC | 6.25% | 12,430,783 | $1.19B | Insider |
| State Street Corp | 4.85% | 9,656,403 | $926.34M | Institution |
| Aqr Capital Management LLC | 3.38% | 6,720,024 | $644.65M | Institution |
| Geode Capital Management LLC | 2.51% | 4,993,012 | $478.98M | Institution |